OraSure Technologies Inc (OSUR)
OraSure Technologies Inc is a biotechnology company specializing in the development, manufacture, and distribution of point-of-care diagnostic tests and sample collection devices. It is known for its focus on infectious disease testing, including HIV, hepatitis, and COVID-19, as well as other health screening and diagnostic solutions. The company's products are used in both healthcare settings and for at-home testing.
Company News
The global at-home testing market is expected to grow from $7.8 billion in 2025 to $11.9 billion by 2035, driven by increasing consumer demand for self-diagnostic tools. Key factors include rising healthcare spending, growing awareness of preventive healthcare, and technological advancements in diagnostic tools.
OraSure Technologies has acquired Sherlock Biosciences, a global health company that develops next-generation diagnostic tests. The acquisition expands OraSure's pipeline with Sherlock's molecular diagnostics platform, which can provide rapid and accurate results for sexually transmitted infections.
OraSure (OSUR) delivered earnings and revenue surprises of 0% and 3.70%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Volatile markets could see a turnaround, and small-cap stocks can be great buy opportunities. Click here to read about 4 small-cap stocks under $10.
Historic or high-tech, walkable and affordable, beaches or mountains, this list of Northeastern cities has something for everyone.